Article
Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome.
Journal of clinical and experimental hematopathology : JCEH - 1 Jan 2023
Nagehan Pakasticali, Sabbir Mirza, Song Jinming, Mohammad Hussaini
Abstract excerpt
Myelodysplastic syndromes (MDS) are myeloid neoplasms that are driven by genetic mutations. Generally, it is thought that a higher number of mutations is associated with worse prognosis. However, the impact of genetic mutations when they occur in the same functional class has not been well studied. Here we investigated the impact of multiple spliceosome mutations on prognosis in MDS patients, hypothesizing that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
